/term/current-deferred-revenue/SZSE:300238 Guanhao Biotech Co (SZSE:300238) Current Deferred Revenue
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Current Deferred Revenue

Guanhao Biotech Co (SZSE:300238) Current Deferred Revenue : ¥0.0 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Guanhao Biotech Co's current deferred revenue for the quarter that ended in Mar. 2024 was ¥0.0 Mil.

Guanhao Biotech Co Current Deferred Revenue Historical Data

The historical data trend for Guanhao Biotech Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Current Deferred Revenue Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Guanhao Biotech Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Guanhao Biotech Co (SZSE:300238) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Current Deferred Revenue
Comparable Companies
SZSE:000710 BJSE:430047 SHSE:603739 SZSE:301166 SZSE:002868 SZSE:300381 SZSE:300147 SZSE:300878 SHSE:688068 SHSE:688670 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Website
http://www.grandhopebio.com
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines